Protecting Your Pathology: Cybersecurity for Digital Workflows
Digital pathology opens up new cybersecurity risks for labs—but simple steps can mitigate those risks and increase digital resilience
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Digital pathology opens up new cybersecurity risks for labs—but simple steps can mitigate those risks and increase digital resilience
From - Diagnostic Testing & Emerging Technologies
Elevated donor-derived, cell-free DNA (ddcfDNA) in the 3 months post-lung transplant can identify clinically silent allograft injury and…
From - Diagnostic Testing & Emerging Technologies
Tumor markers alone may be adequate to monitor for relapse among children and teens with malignant germ cell tumors (MGCTs), according to a study published…
From - Diagnostic Testing & Emerging Technologies
Gene expression profiling has been making inroads into clinical cancer care, with application in cancer classification, most notably with…
From - Diagnostic Testing & Emerging Technologies
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to…
From - Diagnostic Testing & Emerging Technologies
Point-of-care (POC) HbA1c measurements show a high level of agreement with central laboratory test in the outpatient setting…
From - Diagnostic Testing & Emerging Technologies
Given we are still in the midst of cold and flu season, a new study highlights the benefit of point-of-care (POC) polymerase chain reaction (PCR) testing among…
From - Diagnostic Testing & Emerging Technologies
Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment…